Growth Capital • Consumer Products

RoundTable Healthcare Management Invests In Goodier Cosmetics

On August 3, 2016, private equity firm RoundTable Healthcare Management invested in consumer products company Goodier Cosmetics

Investment Context
  • This is RoundTable Healthcare Management’s 3rd transaction in the Consumer Products sector.
  • This is RoundTable Healthcare Management’s 20th transaction in the United States.
  • This is RoundTable Healthcare Management’s 3rd transaction in Texas.
Investment Fate
  • Goodier Cosmetics was sold to a consortium of financial buyers in 2021.

Explore All 560 Growth Capital Consumer Products Deals - Search the Database Free


Investment Summary

Date August 3, 2016
Target Goodier Cosmetics
Sector Consumer Products
Investor(s) RoundTable Healthcare Management
Deal Type Growth Capital

Target Company

Goodier Cosmetics

Dallas, Texas, United States
Goodier Cosmetics is a cGMP-compliant, FDA-registered and OTC-licensed developer and manufacturer of topical skincare products. Operating in over 110,000 square feet of warehouse and manufacturing space, Goodier’s customers include entrepreneurs and companies in need of expert formulation and large-scale filling and manufacturing. Goodier Cosmetics was founded in 1992 and is based in Dallas, Texas.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

RoundTable Healthcare Management

Lake Forest, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 2.9B USD
Size Large
Type Sector Focused
DESCRIPTION

RoundTable Healthcare Partners is a specialist private equity firm that targets equity and junior capital investments in the healthcare industry. Specific areas of interest include medical devices, medical products and disposables, specialty pharmaceuticals, medication delivery systems, specialty distribution, and outsourced healthcare services. RoundTable typically makes equity investments of approximately $5 to $50 million in platform companies with revenues ranging from $25 to $300 million. RoundTable will not invest in service-oriented provider segments (such as managed care companies, hospitals or nursing homes), internet or biotechnology companies, or start-up/venture situations. RoundTable was formed in 2001 and is based in Lake Forest, Illinois.


Deal Context for Investor #
Overall 21 of 31
Sector: Consumer Products 3 of 8
Type: Growth Capital 2 of 4
State: Texas 3 of 3
Country: United States 20 of 30
Year: 2016 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-03 Revision Skincare

Irving, Texas, United States

Revision Skincare providess dermatologists, plastic surgeons, and medical spas with clinically-proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin’s appearance and reducing signs of aging. Revision Skincare is based in Irving, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-20 Deerland Probiotics & Enzymes

Kennesaw, Georgia, United States

Deerland Probiotics & Enzymes is a developer, formulator, and manufacturer of enzyme- and probiotic-based dietary supplements. Deerland specializes in customized product formulations and offers a line of clinically-studied branded ingredients, including its probiotic, DE111, which recently earned Non-GMO Project verification and Health Canada approval. The Company also offers multiple branded enzymes, including its innovative Glutalytic and ProHydrolase products. Deerland Enzymes was founded in 1990 and is based in Kennesaw, Georgia.

Buy -